Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARA Cure FA

Author

Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Executive Director

Display #

Title	Created Date	Category
Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia	Thursday, October 17, 2019	Scientific News
Reata Announces Positive Topline Results from the MOXIe Registrational Trial of Omaveloxolone in Patients with Friedreich’s Ataxia	Monday, October 14, 2019	Supported Research
Primary Cultures of Pure Embryonic Dorsal Root Ganglia Sensory Neurons as a New Cellular Model for Friedreich's Ataxia	Thursday, October 10, 2019	Funded Research
Changes detected in swallowing function in Friedreich ataxia over 12 months	Thursday, October 10, 2019	Funded Research
SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia	Thursday, October 10, 2019	Scientific News
Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich's Ataxia	Tuesday, October 8, 2019	Scientific News
Health-related quality of life and depressive symptoms in Friedreich ataxia	Tuesday, October 1, 2019	Scientific News
Unique roles of iron and zinc binding to the yeast Fe-S cluster scaffold assembly protein "Isu1"	Tuesday, September 24, 2019	Scientific News
Mechanism of activation of the human cysteine desulfurase complex by frataxin	Tuesday, September 24, 2019	Scientific News
Instrumented Data Exchange for Ataxia (IDEA study) Johns Hopkins	Monday, September 16, 2019	Clinical Trials - Active - Enrolling

Page 1 of 78

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End